230 related articles for article (PubMed ID: 7960987)
1. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.
McGinn CJ; Miller EM; Lindstrom MJ; Kunugi KA; Johnston PG; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):851-9. PubMed ID: 7960987
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization by fluorodeoxyuridine: effects of thymidylate synthase inhibition and cell synchronization.
Miller EM; Kinsella TJ
Cancer Res; 1992 Apr; 52(7):1687-94. PubMed ID: 1532343
[TBL] [Abstract][Full Text] [Related]
3. Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression.
Lawrence TS; Davis MA; Tang HY; Maybaum J
Int J Radiat Biol; 1996 Sep; 70(3):273-80. PubMed ID: 8800198
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitivity of thymidylate synthase-deficient human tumor cells is affected by progression through the G1 restriction point into S-phase: implications for fluoropyrimidine radiosensitization.
Hwang HS; Davis TW; Houghton JA; Kinsella TJ
Cancer Res; 2000 Jan; 60(1):92-100. PubMed ID: 10646859
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells.
Bruso CE; Shewach DS; Lawrence TS
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1411-7. PubMed ID: 2148170
[TBL] [Abstract][Full Text] [Related]
6. Dependence of fluorodeoxyuridine-mediated radiosensitization on S phase progression.
Davis MA; Tang HY; Maybaum J; Lawrence TS
Int J Radiat Biol; 1995 May; 67(5):509-17. PubMed ID: 7775826
[TBL] [Abstract][Full Text] [Related]
7. Lack of dependence of 5-fluorodeoxyuridine-mediated radiosensitization on cytotoxicity.
Lawrence TS; Davis MA; Chang EY; Canman CE; Maybaum J; Radany EH
Radiat Res; 1995 Sep; 143(3):281-5. PubMed ID: 7652165
[TBL] [Abstract][Full Text] [Related]
8. 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells.
Parsels LA; Parsels JD; Tai DC; Coughlin DJ; Maybaum J
Cancer Res; 2004 Sep; 64(18):6588-94. PubMed ID: 15374972
[TBL] [Abstract][Full Text] [Related]
9. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
[TBL] [Abstract][Full Text] [Related]
10. Induction of cell cycle-dependent cytotoxicity and apoptosis by new heterodinucleoside phosphate dimers of 5-fluorodeoxyuridine in PC-3 human prostate cancer cells.
Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Derighetti M; Schwendener RA
Biochem Pharmacol; 2000 Dec; 60(12):1887-96. PubMed ID: 11108805
[TBL] [Abstract][Full Text] [Related]
11. Radiation sensitization of mammalian cells by metal chelators.
Cook J
Radiat Res; 2001 Feb; 155(2):304-10. PubMed ID: 11175665
[TBL] [Abstract][Full Text] [Related]
12. Use of fluorescence in situ hybridization (FISH) to study chromosomal damage induced by radiation and bromodeoxyuridine in human colon cancer cells.
Wilt SR; Burgess AC; Normolle DP; Trent JM; Lawrence TS
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):861-6. PubMed ID: 7960988
[TBL] [Abstract][Full Text] [Related]
13. The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine.
Ostruszka LJ; Shewach DS
Cancer Res; 2000 Nov; 60(21):6080-8. PubMed ID: 11085531
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells.
Grem JL; Danenberg KD; Kao V; Danenberg PV; Nguyen D
Anticancer Drugs; 2002 Mar; 13(3):259-70. PubMed ID: 11984070
[TBL] [Abstract][Full Text] [Related]
15. HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells.
Axelson MD; Davis MA; Ethier SP; Lawrence TS
Neoplasia; 1999 Jun; 1(2):177-82. PubMed ID: 10933053
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization by pemetrexed of human colon carcinoma cells in different cell cycle phases.
Bischof M; Huber P; Stoffregen C; Wannenmacher M; Weber KJ
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):289-92. PubMed ID: 12909245
[TBL] [Abstract][Full Text] [Related]
17. Influence of cell cycle phase on radiation-induced cytotoxicity and DNA damage in human colon cancer (HT29) and Chinese hamster ovary cells.
Tang H; Davis MA; Strickfaden SM; Maybaum J; Lawrence TS
Radiat Res; 1994 Apr; 138(1 Suppl):S109-12. PubMed ID: 8146311
[TBL] [Abstract][Full Text] [Related]
18. The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization.
Naida JD; Davis MA; Lawrence TS
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):675-80. PubMed ID: 9635719
[TBL] [Abstract][Full Text] [Related]
19. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells.
Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Rothen-Rutishauser B; Guenthert M; Schwendener RA
J Cancer Res Clin Oncol; 2000 May; 126(5):247-56. PubMed ID: 10815759
[TBL] [Abstract][Full Text] [Related]
20. BrdUrd-induced radiosensitization of two human tumour cell lines at iso-levels of incorporation.
Franken NA; Van Bree C; Kipp JB; Rodermond HM; Haveman J; Barendsen GW
Oncol Rep; 2000; 7(5):937-40. PubMed ID: 10948317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
